Abstract:Aim: To study the influence of redox environment of Escherichia coli (E. coli) cytoplasm on disulfide bond formation of recombinant proteins. Methods: Bovine fibroblast growth factor (BbFGF) was selected as a model of simple proteins with a single disulfide bond and free cysteines. Anti-HBsAg single-chain Fv (HBscFv), an artificial multidomain protein, was selected as the model molecule of complex protein with 2 disulfide bonds. A BbFGF-producing plasmid, pJN-BbFGF, and a HBscFv producing-plasmid, pQE-HBscFv, were constructed and transformed into E. coli strains BL21(DE3) and M15(pREP4) respectively. At the same time, both plasmids were transformed into a reductase-deficient host strain, E. coli Origami(DE3). The 4 recombinant E. coli strains were cultured and the target proteins were purified. Solubility and bioactivity of recombinant BbFGF and HBscFv produced in different host strains were analyzed and compared respectively. Results: All recombinant E. coli strains could efficiently produce target proteins. The level of BbFGF in BL21(DE3) was 15-23% of the total protein, and was 5-10% in Origami (DE3). In addition, 65% of the BbFGF produced in BL21(DE3) formed into inclusion body in the cytoplasm, and all the target proteins became soluble in Origami(DE3). The bioactivity of BbFGF purified from Origami(DE3) was higher than its counterpart from BL21(DE3). The ED(50) of BbFGF from Origami(DE3) and BL21(DE3) was 1.6 microg/L and 2.2 microg/L, respectively. Both HBscFv formed into inclusion body in the cytoplasm of M15(pQE-HBscFv) or Origami(pQE-HBscFv). But the supernatant of Origami(pQE-HBscFv) lysate displayed weak bioactivity and its counterpart from M15(pQE-HBscFv) did not display any bioactivity. The soluble HBscFv in Origami(pQE-HBscFv) was purified to be 1-2 mg/L and its affinity constant was determined to be 2.62 x 10(7) mol/L. The yield of native HBscFv refolded from inclusion body in M15(pQE-HBscFv) was 30-35 mg/L and the affinity constant was 1.98 x 10(7) mol/L. There was no significant difference between the bioactivity of HBscFvs refolded from the inclusion bodies produced in different host strains. Conclusion: Modification of the redox environment of E. coli cytoplasm can significantly improve the folding of recombinant disulfide-bonded proteins produced in it.

Comparing the Soluble Form of Recombinant Human Insulin-like Growth Factor-1 (rhIGF-1) in Escherichia coli Using Thioredoxin as Fused and Co-expressed Protein.

High-Level Soluble Expression of Higf-1 Fusion Protein in Recombinant Escherichia Coli

Fed-batch Production of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) in Soluble Form in Escherichia Coli and Its Purification and Characterization.

Soluble expression of human insulin-like growth factor-1 with the assistance of SUMO fusion partner

Soluble Expression and Biological Activity Detection of Recombinant Human Insulin Like Growth Factor 1 in Prokaryotic System

Expression of biologically active human insulin-like growth factor 1 in Arabidopsis thaliana seeds via oleosin fusion technology.

Recombinant expression of IGF-1 and LR3 IGF-1 fused with xylanase in Pichia pastoris

High-level Expression of Human Truncated Insulin-Like Growth Factor 1 in E.coli

Extracellular Production of Human Parathyroid Hormone As a Thioredoxin Fusion Form in Escherichia Coli by Chemical Permeabilization Combined with Heat Treatment.

Construction of Prokaryotic Expression Vector for Human Insulin-like Growth Factor-1 Gene and Biological Activity of Expressed Protein

Solubility of disulfide-bonded proteins in the cytoplasm of Escherichia coli and its "oxidizing" mutant

A rapid method for solubilization of chimeric human interferon regulatory factor-1 (IRF-1) protein in Escherichia coli

Integrated bioprocessing and genetic strategies to enhance soluble expression of anti-HER2 immunotoxin in E. Coli

Effects of Thioredoxin: SUMO and Intein on Soluble Fusion Expression of an Antimicrobial Peptide OG2 in Escherichia Coli

Expression of soluble, biologically active recombinant human endostatin in Escherichia coli

Evaluation of soluble expression of recombinant granulocyte macrophage stimulating factor (rGM-CSF) by three different E. coli strains

GroEL/ES Mediated the in Vivo Recovery of TRAIL Inclusion Bodies in Escherichia Coli.

Effects of E. coli Chaperones on the Solubility of Human Receptors in an In Vitro Expression System

Enhanced Production of Soluble Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand in Escherichia Coli Using a Novel Self-Cleavable Tag System Fh8-ΔI-CM.

Expression and Characterization of Insulin Growth Factor-I-enhanced Green Fluorescent Protein Fused Protein As a Tracer for Immunoassay.

A simplified method for the efficient purification and refolding of recombinant human TRAIL